You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 9, May 11, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  In This Issue of Archives of Internal Medicine
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

In This Issue of Archives of Internal Medicine

Arch Intern Med. 2009;169(9):827.

A Comprehensive Pharmacist Intervention to Reduce Morbidity in Patients 80 Years or Older

Drug-related problems are common reasons for hospital visits, especially among elderly patients. In this prospective, randomized controlled trial of patients 80 years and older, Gillespie et al found that interventions performed by ward-based pharmacists reduced the total number of visits to a hospital by 16%, drug-related admissions by 80%, and costs by $267 per patient compared with standard care. They conclude that adding pharmacists to health care teams should lead to major reductions in drug-related morbidity and health care costs.

(SEE ARTICLE)


Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences

Previous social science research suggests that small promotional items of minimal value influence attitudes and decisions toward marketed products. However, physicians generally do not believe they are influenced by such pharmaceutical promotional items, which is reflected in US medical ethics guidelines. In this randomized experimental study of medical students at 2 US schools, Grande et al found that brief exposures to pharmaceutical promotional items favorably influence implicit (ie, unconscious) attitudes for the marketed product. However, in the setting of restrictive policies limiting pharmaceutical marketing activities and negative attitudes toward marketing, the effect is reversed.

(SEE ARTICLE)


Consistency With the DASH Diet and Incidence of Heart Failure

The Dietary Approaches to Stop Hypertension (DASH) diet, which is characterized by high intake of fruits, vegetables, low-fat dairy products, and whole grains, has been shown to reduce blood pressure in trials. Because of the effect on blood pressure and other potential cardiovascular benefits, this eating pattern may reduce the incidence of heart failure. Diet was measured using food frequency questionnaires in 36 019 women aged 48 to 83 years, who were classified by consistency with the DASH diet. The women were followed up for heart failure hospitalization or mortality from 1998 through 2004. Compared with the lowest 25%, women who were in the top 25% based on ranking components of the DASH diet had a 37% lower rate of heart failure (95% confidence interval, 19%-52%). The pattern of the association with heart failure was similar for scores using other strategies to measure consistency with the DASH diet.

(SEE ARTICLE)


A Randomized Trial Comparing Acupuncture, Simulated Acupuncture, and Usual Care for Chronic Low Back Pain

This trial addresses the importance of needle placement and skin penetration in eliciting acupuncture effects for patients with chronic low back pain. A total of 638 adults with chronic mechanical low back pain were randomized to individualized acupuncture, standardized acupuncture, simulated acupuncture, or usual care. At 8 weeks, after up to 10 treatments, participants receiving real or simulated acupuncture fared equally well but were more likely than those receiving usual care to experience clinically meaningful improvements. Some of the treatment benefits persisted for 1 year. Although acupuncture was found to be effective for chronic low back pain, tailoring needling sites to each patient and penetration of the skin appears to be unimportant in eliciting therapeutic benefits.

(SEE ARTICLE)


Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors

Cholinesterase inhibitors are commonly used to treat dementia, but these drugs can provoke bradycardia and syncope. These underrecognized adverse drug effects may then contribute to permanent pacemaker insertion and fall-related injuries such as hip fracture. In a population-based cohort study, Gill et al report that cholinesterase inhibitor use increased the risk of syncope-related outcomes including pacemaker insertion and hip fracture. Clinicians should carefully consider these findings when weighing the potential benefits and risks of cholinesterase inhibitor treatment for their patients with dementia.


Figure 90000FA
Conceptualizing syncope-related outcomes.


(SEE ARTICLE)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.